Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide
- PMID: 15149151
Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide
Abstract
The purpose of this study was to compare the results obtained with superparamagnetic iron oxide-enhanced and unenhanced Magnetic Resonance at 1.5 T with that of spiral-computed tomography (CT) in order to select those patients suitable for liver resection; the intraoperative US (IOUS) comprised the gold standard. Thirty five candidates for liver resection with known colorectal neoplasm were studied; 26 patients underwent surgery, one patient underwent RF ablation and 8 of them were submitted to follow-up. MR examination was performed using a 1.5 T superconductive instrument, CT examination was performed on a Somatom-Plus (Siemens) scanner. Dimensions and number of the lesions were defined in all patients as well as the sensitivity of spiral CT and MR imaging, using either the plain technique or after Ferumoxides c.m.. In those patients submitted to surgery, results have been correlated to those of IOUS. From 26 patients, a total of 48 lesions were removed surgically. With CT, 34 lesions with 3 false positive cases were detected; 32 with plain MR imaging, while MR imaging with Ferumoxides detected 41 lesions. In the patients not submitted to surgery, MR iron-oxide imaging identified 15 lesions, while both plain MR imaging and CT showed 8 lesions. The smallest lesion was 6 mm. as shown by MR imaging with Ferumoxides. In the cases submitted to surgery, the CT sensitivity was 71%, plain MR imaging 66% and MR imaging with Ferumoxides 85%. In our experience, Ferumoxides-enhanced MR imaging of the liver shows increased sensitivity compared to plain and spiral-CT in the evaluation of hepatic metastases. We think that MR superparamagnetic iron oxide should be used in all patients selected for liver resection.
Similar articles
-
Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.Abdom Imaging. 2007 Sep-Oct;32(5):624-34. doi: 10.1007/s00261-007-9297-y. Abdom Imaging. 2007. PMID: 17710359
-
Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.J Magn Reson Imaging. 2011 Aug;34(2):326-35. doi: 10.1002/jmri.22613. J Magn Reson Imaging. 2011. PMID: 21780227
-
Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging.J Clin Gastroenterol. 2007 Sep;41(8):789-95. doi: 10.1097/01.mcg.0000225676.22218.08. J Clin Gastroenterol. 2007. PMID: 17700429
-
MR imaging in the evaluation of hepatic metastases.Magn Reson Imaging Clin N Am. 2000 Nov;8(4):741-56. Magn Reson Imaging Clin N Am. 2000. PMID: 11149677 Review.
-
[Role of imaging in abdominopelvic follow-up after resection of colorectal cancer].J Chir (Paris). 1997 Jul;134(2):51-8. J Chir (Paris). 1997. PMID: 9378784 Review. French.
Cited by
-
Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?Korean J Hepatobiliary Pancreat Surg. 2011 Nov;15(4):206-17. doi: 10.14701/kjhbps.2011.15.4.206. Epub 2011 Dec 15. Korean J Hepatobiliary Pancreat Surg. 2011. PMID: 26421041 Free PMC article.
-
Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.Ir J Med Sci. 2012 Dec;181(4):499-509. doi: 10.1007/s11845-012-0805-x. Epub 2012 Mar 17. Ir J Med Sci. 2012. PMID: 22426901
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical